Multiple studies have confirmed that the tumor inflammatory tumor microenvironment can activate the axis of COX-2/PGE-2/Bcl-2 pathway, thereby activating the expression of the antiapoptotic gene Bcl-2 in downstream tumor cells and enhancing the antiapoptotic ability of tumor cells [22]. The gene discussed is BCL2; the disease is neoplasm.